Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio D'Ascenzo and Fabrizio Ugo.
Connection Strength
2.218
-
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry. Int J Cardiol. 2021 06 01; 332:227-234.
Score: 0.234
-
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak. Am J Cardiovasc Dis. 2020; 10(4):506-513.
Score: 0.227
-
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):283-288.
Score: 0.192
-
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry. Eur Heart J Cardiovasc Imaging. 2018 05 01; 19(5):524-531.
Score: 0.191
-
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial. Int J Cardiol. 2018 04 15; 257:1-6.
Score: 0.191
-
Diagnostic accuracy of functional, imaging and biochemical tests for patients presenting with chest pain to the emergency department: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2019 Aug; 8(5):412-420.
Score: 0.188
-
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients. Eur Heart J. 2017 Nov 07; 38(42):3160-3172.
Score: 0.185
-
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis. Int J Cardiol. 2017 Oct 01; 244:54-58.
Score: 0.180
-
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). Am J Cardiol. 2017 Apr 01; 119(7):978-982.
Score: 0.175
-
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy. Int J Cardiol. 2021 06 01; 332:235-237.
Score: 0.058
-
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak. ESC Heart Fail. 2020 Oct 23.
Score: 0.057
-
Outcomes of acute coronary syndromes in coronavirus disease 2019. Clin Res Cardiol. 2020 Dec; 109(12):1601-1604.
Score: 0.056
-
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med. 2020 07 02; 383(1):88-89.
Score: 0.055
-
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]. Int J Cardiol. 2018 07 15; 263:188.
Score: 0.049
-
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. Int J Cardiol. 2018 Jan 01; 250:80-85.
Score: 0.046
-
Culprit plaque characteristics in younger versus older patients with acute coronary syndromes: An optical coherence tomography study from the FORMIDABLE registry. Catheter Cardiovasc Interv. 2018 07; 92(1):E1-E8.
Score: 0.045
-
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. Am J Cardiol. 2017 07 01; 120(1):33-39.
Score: 0.044
-
Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):E46-E52.
Score: 0.044